TY - JOUR
T1 - Annual costs attributed to atrial fibrillation management: cross-sectional study of primary healthcare electronic records
AU - Casajuana, Marc
AU - Giner-Soriano, Maria
AU - Roso-Llorach, Albert
AU - Vedia, Cristina
AU - Violan, Concepció
AU - Morros, Rosa
PY - 2018/11/1
Y1 - 2018/11/1
N2 - © 2018, Springer-Verlag GmbH Germany, part of Springer Nature. Atrial fibrillation (AF) is the most common chronic arrhythmia, with increasing healthcare and economic burden and a prevalence which increases with progressive ageing. This study aims to describe overall annual costs per patient for management of non-valvular AF in a primary healthcare (PHC) setting and compare these costs between the groups of patients treated with vitamin K antagonists, antiplatelets or non-treated through a population-based study conducted with electronic health records. We analysed annual costs per person of 19,787 patients in 2012; PHC visits, hospital admissions, AF-related events requiring hospital admission, referrals to secondary specialists, sick leave, diagnostic tests and laboratory tests at PHC level, including INR determinations performed in PHC, and drug therapy. Higher costs of AF management were associated with increasing age, male sex, stroke and bleeding risks, comorbidities and occurrence of events associated to AF. The sensitivity analyses conducted showed that PHC visits and hospitalizations represented the most important part of overall costs for all patients.
AB - © 2018, Springer-Verlag GmbH Germany, part of Springer Nature. Atrial fibrillation (AF) is the most common chronic arrhythmia, with increasing healthcare and economic burden and a prevalence which increases with progressive ageing. This study aims to describe overall annual costs per patient for management of non-valvular AF in a primary healthcare (PHC) setting and compare these costs between the groups of patients treated with vitamin K antagonists, antiplatelets or non-treated through a population-based study conducted with electronic health records. We analysed annual costs per person of 19,787 patients in 2012; PHC visits, hospital admissions, AF-related events requiring hospital admission, referrals to secondary specialists, sick leave, diagnostic tests and laboratory tests at PHC level, including INR determinations performed in PHC, and drug therapy. Higher costs of AF management were associated with increasing age, male sex, stroke and bleeding risks, comorbidities and occurrence of events associated to AF. The sensitivity analyses conducted showed that PHC visits and hospitalizations represented the most important part of overall costs for all patients.
KW - Atrial fibrillation
KW - Costs
KW - Electronic health records
KW - Haemorrhage
KW - I10
KW - Primary healthcare
KW - Stroke
U2 - 10.1007/s10198-018-0961-7
DO - 10.1007/s10198-018-0961-7
M3 - Article
C2 - 29464418
VL - 19
SP - 1129
EP - 1136
JO - European Journal of Health Economics
JF - European Journal of Health Economics
SN - 1618-7598
ER -